PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trialFahong Li, Jiming Zhang, Lihong Qu et al.|Journal of Hepatology|2024Cited by 18